Inspira Technologies Oxy B.H.N. Ltd. (IINN) began an AME technology implementation on April 13 2026 with a customer ranked among the world’s ten largest U.S. companies, marking the first practical deployment of its Additive Manufactured Electronics platform in a major corporate environment.
The AME platform was acquired from Nano Dimension for up to $12.5 million, and Inspira plans to rebrand as QTREX Ltd. to reflect its new focus on quantum‑computing connectivity. The implementation is centered on a U.S. research and development facility, where the company will integrate cryogenic connectivity solutions that address a critical bottleneck in dilution cryostats used to scale quantum systems.
By validating the AME platform with a high‑profile customer, Inspira opens a path to recurring revenue and strengthens its position in the high‑growth quantum‑hardware market. The company will continue to operate its medical‑technology portfolio—such as the INSPIRA™ ART100 and HYLA™ blood‑monitoring systems—through a dedicated subsidiary, preserving diversification while pursuing its quantum strategy.
CEO Dagi Ben‑Noon said, “We view this type of engagement as confirmation of the practical relevance of our AME platform. We are not speaking about theoretical potential. We are engaged in an active implementation process with a paying customer ranked among the largest companies in the world, a company with the resources, expertise, and infrastructure to validate our AME technology at the highest level.”
McKinsey projects the quantum‑computing market to reach $72 billion by 2035, and Inspira’s focus on cryogenic connectivity positions it to capture a share of the growing demand for scalable quantum systems. The partnership signals strong demand for the company’s solutions and suggests that additional contracts with other large enterprises may follow.
This milestone demonstrates Inspira’s ability to translate a newly acquired technology into a commercial offering, signals a strategic pivot toward quantum‑computing infrastructure, and provides a foundation for future revenue growth in a rapidly expanding market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.